These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2252756)

  • 1. Influence of phosphatidylcholine on ultrafiltration and solute transfer in CAPD patients.
    Querques M; Procaccini DA; Pappani A; Strippoli P; Passione A
    ASAIO Trans; 1990; 36(3):M581-3. PubMed ID: 2252756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of calcium antagonists on the peritoneal membrane in patients on CAPD.
    Vargemezis V; Pasadakis P; Thodis E
    Adv Perit Dial; 1989; 5():8-11. PubMed ID: 2577433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intraperitoneal pressure, ultrafiltration and purification dwell times for individual peritoneal dialysis prescription in children.
    Fischbach M; Desprez P; Terzic J; Lahlou A; Mengus L; Geisert J
    Clin Nephrol; 1996 Jul; 46(1):14-6. PubMed ID: 8832143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidylcholine administration in continuous ambulatory peritoneal dialysis (CAPD) patients with reduced ultrafiltration.
    De Vecchi A; Castelnovo C; Guerra L; Scalamogna A
    Perit Dial Int; 1989; 9(3):207-10. PubMed ID: 2488367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis.
    Mactier RA; Khanna R; Twardowski Z; Moore H; Nolph KD
    J Clin Invest; 1987 Nov; 80(5):1311-6. PubMed ID: 3680499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal administration of phosphatidylcholine improves ultrafiltration in continuous ambulatory peritoneal dialysis patients.
    Krack G; Viglino G; Cavalli PL; Gandolfo C; Magliano G; Cantaluppi A; Peluso F
    Perit Dial Int; 1992; 12(4):359-64. PubMed ID: 1420493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal comparison of intermittent versus continuous ambulatory peritoneal dialysis, in the same patients.
    Madden MA; Zimmerman SW; Simpson DP
    Clin Nephrol; 1981 Dec; 16(6):293-9. PubMed ID: 6797767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE; de Waart DR; Struijk DG; Krediet RT
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peritoneal blood flow, peritoneal transfer and continuous ambulatory peritoneal dialysis].
    Grzegorzewska A; Sliwowski A
    Pol Merkur Lekarski; 1997 Sep; 3(15):122-5. PubMed ID: 9461708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyglucose dialysis solution induces changes in blood chemistry.
    Grzegorzewska AE; Antczak-Jedrzejczak D; Leander M; Mariak I
    Adv Perit Dial; 2001; 17():101-8. PubMed ID: 11510254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients.
    Davies SJ
    Kidney Int; 2004 Dec; 66(6):2437-45. PubMed ID: 15569337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative evaluation of CAPD and PD-plus effectiveness.
    Iles-Smith H; Curwell J; Gokal R
    EDTNA ERCA J; 1999; 25(3):27-9. PubMed ID: 10786491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis.
    Chan PC; Tam SC; Robinson JD; Yu L; Ip MS; Chan CY; Cheng IK
    Nephron; 1991; 59(1):100-3. PubMed ID: 1944720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Automatic peritoneal dialysis--an adequate therapy option for the treatment of terminal kidney failure. First experiences with a new, pneumatically operated cycler].
    Busch T; Plum J; Grabensee B
    Dtsch Med Wochenschr; 1996 Sep; 121(38):1145-51. PubMed ID: 8925734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognosis and changes of peritoneal function in CAPD and APD patients].
    Yokoyama K
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):259-70. PubMed ID: 8196223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating peritoneal fluid transport in continuous peritoneal dialysis patients: a practical approach.
    Zhe XW; Tian XK; Shan YS; Cheng L; Wang T
    Nephron Clin Pract; 2007; 107(4):c123-7. PubMed ID: 17957122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized prospective study of the effect of increased dialytic dose on nutritional and clinical outcome in continuous ambulatory peritoneal dialysis patients.
    Mak SK; Wong PN; Lo KY; Tong GM; Fung LH; Wong AK
    Am J Kidney Dis; 2000 Jul; 36(1):105-14. PubMed ID: 10873879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urea kinetic modelling in two groups of patients on continuous ambulatory peritoneal dialysis.
    Barton EN; Morgan AG; Burden RP
    West Indian Med J; 1997 Jun; 46(2):57-9. PubMed ID: 9260536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal phosphate clearance is influenced by peritoneal dialysis modality, independent of peritoneal transport characteristics.
    Badve SV; Zimmerman DL; Knoll GA; Burns KD; McCormick BB
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1711-7. PubMed ID: 18815242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.